Correlation Between Neurocrine Biosciences and 25160PAE7

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and 25160PAE7 at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and 25160PAE7 into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and DEUTSCHE BK AG, you can compare the effects of market volatilities on Neurocrine Biosciences and 25160PAE7 and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of 25160PAE7. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and 25160PAE7.

Diversification Opportunities for Neurocrine Biosciences and 25160PAE7

-0.72
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Neurocrine and 25160PAE7 is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and DEUTSCHE BK AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on DEUTSCHE BK AG and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with 25160PAE7. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of DEUTSCHE BK AG has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and 25160PAE7 go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and 25160PAE7

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 1.83 times more return on investment than 25160PAE7. However, Neurocrine Biosciences is 1.83 times more volatile than DEUTSCHE BK AG. It trades about 0.02 of its potential returns per unit of risk. DEUTSCHE BK AG is currently generating about 0.03 per unit of risk. If you would invest  12,295  in Neurocrine Biosciences on September 26, 2024 and sell it today you would earn a total of  1,404  from holding Neurocrine Biosciences or generate 11.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy77.22%
ValuesDaily Returns

Neurocrine Biosciences  vs.  DEUTSCHE BK AG

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
DEUTSCHE BK AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DEUTSCHE BK AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 25160PAE7 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Neurocrine Biosciences and 25160PAE7 Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and 25160PAE7

The main advantage of trading using opposite Neurocrine Biosciences and 25160PAE7 positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, 25160PAE7 can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in 25160PAE7 will offset losses from the drop in 25160PAE7's long position.
The idea behind Neurocrine Biosciences and DEUTSCHE BK AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon